DXCM vs ECL · P/E 63, rev $4.03B vs P/E 35, rev $4.01B
DexCom Inc (DXCM) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the DXCM and ECL stock pages for the full models.
Not investment advice.